Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Treatment of Lyme Arthritis

ALLEN C. STEERE
The Journal of Rheumatology August 2019, 46 (8) 871-873; DOI: https://doi.org/10.3899/jrheum.190320
ALLEN C. STEERE
Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: asteere@partners.org
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Mead PS
    . Epidemiology of Lyme disease. Infect Dis Clin North Am 2015;29:187–210.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Ogden NH,
    2. Lindsay LR,
    3. Morshed M,
    4. Sockett PN,
    5. Artsob H
    . The rising challenge of Lyme borreliosis in Canada. Can Commun Dis Rep 2008;34:1–19.
    OpenUrlPubMed
  3. 3.↵
    1. Steere AC
    . Lyme disease. N Engl J Med 1989;321:586–96.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Wormser GP,
    2. Dattwyler RJ,
    3. Shapiro ED,
    4. Halperin JJ,
    5. Steere AC,
    6. Klempner MS,
    7. et al.
    The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089–134.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Steere AC,
    2. Schoen RT,
    3. Taylor E
    . The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725–31.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Steere AC,
    2. Levin RE,
    3. Molloy PJ,
    4. Kalish RA,
    5. Abraham JH 3rd,
    6. Liu NY,
    7. et al.
    Treatment of Lyme arthritis. Arthritis Rheum 1994;37:878–88.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Steere AC,
    2. Angelis SM
    . Therapy for Lyme arthritis; strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 2006;54:3079–85.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Lochhead RB,
    2. Arvikar SL,
    3. Aversa JM,
    4. Sadreyev RI,
    5. Strle K,
    6. Steere AC
    . Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with post-infectious, Borrelia burgdorferi-induced Lyme arthritis. Cell Microbiol 2018:e12954.
  9. 9.↵
    1. Li X,
    2. McHugh G,
    3. Damle N,
    4. Sikand VK,
    5. Glickstein L,
    6. Steere AC
    . Burden and viability of Borrelia burgdorferi in skin or joints of patients with erythema migrans or Lyme arthritis. Arthritis Rheum 2011;63:2238–47.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Arvikar SL,
    2. Steere AC
    . Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am 2015;29:269–80.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Pachner AR,
    2. Delaney E,
    3. O’Neill T,
    4. Major E
    . Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology 1995;45:165–72.
    OpenUrl
  12. 12.↵
    1. Dattwyler RJ,
    2. Halperin JJ,
    3. Volkman DJ,
    4. Luft BJ
    . Treatment of late Lyme borreliosis — randomized comparison of ceftriaxone and penicillin. Lancet 1988;1:1191–4.
    OpenUrlPubMed
  13. 13.↵
    1. Qin YF,
    2. Li ZJ,
    3. Li H
    . Corticosteroids as adjunctive therapy with antibiotics in the treatment of children with septic arthritis: a meta-analysis. Drug Des Devel Ther 2018;12:2277–84.
    OpenUrl
  14. 14.↵
    1. Horton DB,
    2. Taxter AJ,
    3. Davidow AL,
    4. Groh B,
    5. Sherry DD,
    6. Rose CD
    . Intraarticular glucocorticoid injection as second-line treatment for Lyme arthritis in children. J Rheumatol 2019;46:952–9.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Horton DB,
    2. Taxter AJ,
    3. Davidow AL,
    4. Groh B,
    5. Sherry DD,
    6. Rose CD
    . Pediatric antibiotic-refractory Lyme arthritis: a multicenter case-control study. J Rheumatol 2019;46:943–51.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Nigrovic PA,
    2. Raychaudhuri S,
    3. Thompson SD
    . Review: genetics and the classification of arthritis in adults and children. Arthritis Rheumatol 2018;70:7–17.
    OpenUrl
  17. 17.↵
    1. Bockenstedt LK,
    2. Wormser GP
    . Review: unraveling Lyme disease. Arthritis Rheumatol 2014;66:2313–23.
    OpenUrl
  18. 18.↵
    1. Arvikar S,
    2. Kohler M,
    3. Oza A,
    4. Steere AC
    . Ultrasonographic examinations show highly prevalent abnormalities of hamstring tendons in Lyme arthritis patients [abstract]. Arthritis Rheumatol 2018;70 Suppl 10:950.
    OpenUrl
  19. 19.↵
    1. Szer IS,
    2. Taylor E,
    3. Steere AC
    . The long-term course of children with Lyme arthritis. N Engl J Med 1991;325:159–63.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Hanincova K,
    2. Mukherjee P,
    3. Ogden NH,
    4. Margos G,
    5. Wormser GP,
    6. Reed KD,
    7. et al.
    Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One 2013;8:e73066.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Strle K,
    2. Shin JJ,
    3. Glickstein LJ,
    4. Steere AC
    . Association of a toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum 2012;64:1497–507.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Jones KL,
    2. McHugh GA,
    3. Glickstein LJ,
    4. Steere AC
    . Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: high frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis. Arthritis Rheum 2009;60:2174–82.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Lochhead RB,
    2. Strle K,
    3. Kim ND,
    4. Kohler MJ,
    5. Arvikar SL,
    6. Aversa JM,
    7. et al.
    MicroRNA expression shows inflammatory dysregulation and tumor-like proliferative responses in joints of patients with post-infectious Lyme arthritis. Arthritis Rheumatol 2017;69:1100–10.
    OpenUrl
  24. 24.↵
    1. Drouin EE,
    2. Seward RJ,
    3. Strle K,
    4. McHugh G,
    5. Katchar K,
    6. Londono D,
    7. et al.
    A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease. Arthritis Rheum 2013;65:186–96.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Crowley JT,
    2. Strle K,
    3. Drouin EE,
    4. Pianta A,
    5. Arvikar SL,
    6. Wang Q,
    7. et al.
    Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis. J Autoimmun 2016;69:24–37.
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 8
1 Aug 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment of Lyme Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Treatment of Lyme Arthritis
ALLEN C. STEERE
The Journal of Rheumatology Aug 2019, 46 (8) 871-873; DOI: 10.3899/jrheum.190320

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Treatment of Lyme Arthritis
ALLEN C. STEERE
The Journal of Rheumatology Aug 2019, 46 (8) 871-873; DOI: 10.3899/jrheum.190320
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease
  • Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis?
  • Practical Issues Relating to the Use of Antifibrotic Therapy in Patients With Interstitial Lung Disease and Rheumatoid Arthritis
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire